Connecticut Neurosurgical Spec Bridgeport, CT - 06610

Connecticut Neurosurgical Spec is categorized under Surgeons in Bridgeport, CT and active since 1988.

Connecticut Neurosurgical Spec was established in 1988, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Kenneth Lipow at the company’s single location by writing to 267 Grant St, Bridgeport, Connecticut CT 06610 or by phoning (203) 384-4500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Connecticut Neurosurgical Spec
Contact Person: Kenneth Lipow
Address: 267 Grant St, Bridgeport, Connecticut 06610
Phone Number: (203) 384-4500
Website Address: bridgeporthospital.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1988
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Surgeons
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Connecticut Neurosurgical Spec was started in 1988 to provide professional Surgeons under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Kenneth Lipow for inquiries that concern Connecticut Neurosurgical Spec by calling the company number (203) 384-4500, as your correspondence is most welcome. Additionally, the physical location of the single location of Connecticut Neurosurgical Spec can be found at the coordinates 41.18884,-73.16655 as well as the street address 267 Grant St in Bridgeport, Connecticut 06610.

For its online presence, you may visit Connecticut Neurosurgical Spec’s website at bridgeporthospital.com and engage with its social media outlets through on Twitter and on Facebook.